Abstract:Amyloid plaque deposition is recognized as the primary pathological hallmark of Alzheimers disease(AD) that precedes other pathological events and cognitive symptoms. Plaque pathology represents itself with an immense polymorphic variety comprising plaques with different stages of amyloid fibrillization ranging from diffuse to fibrillar, mature plaques. The association of polymorphic Abeta plaque pathology with AD pathogenesis, clinical symptoms and disease progression remains unclear. Advanced chemical imaging tools, such as functional amyloid microscopy combined with MALDI mass spectrometry imaging (MSI), are now enhanced by deep learning algorithms. This integration allows for precise delineation of polymorphic plaque structures and detailed identification of their associated Abeta compositions. We here set out to make use of these tools to interrogate heterogenic plaque types and their associated biochemical architecture. Our findings reveal distinct Abeta signatures that differentiate diffuse plaques from fibrilized ones, with the latter showing substantially higher levels of Abeta x-40. Notably, within the fibrilized category, we identified a distinct subtype known as coarse-grain plaques. Both in sAD and fAD brain tissue, coarse grain plaques contained more Abeta x-40 and less Abeta x-42 compared with cored plaques. The coarse grain plaques in both sAD and fAD also showed higher levels of neuritic content including paired helical filaments (PHF-1)/phosphorylated phospho Tau-immunopositive neurites. Finally, the Abeta; peptide content in coarse grain plaques resembled that of vascular Abeta deposits (CAA) though with relatively higher levels of Abeta 1-42 and pyroglutamated Abeta x-40 and Abeta x-42 species in coarse grain plaques. This is the first of its kind study on spatial in situ biochemical characterization of different plaque morphotypes demonstrating the potential of the correlative imaging techniques used that further increase the understanding of heterogeneous AD pathology. Linking the biochemical characteristics of amyloid plaque polymorphisms with various AD etiologies and toxicity mechanisms is crucial. Understanding the connection between plaque structure and disease pathogenesis can enhance our insights. This knowledge is particularly valuable for developing and advancing novel, amyloid-targeting therapeutics.

Senile Plaques in Alzheimer's Disease Arise from Aβ‐ and Cathepsin D‐enriched Mixtures Leaking out During Intravascular Haemolysis and Microaneurysm Rupture

Senile Plaques in Alzheimer’s Disease Arise from Aβ and Cathepsin D-enriched Amyloidogenic Mixtures out of Intravascular Hemolysis and Charcot-Bouchard Aneurysm-Related Vascular Degeneration

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Three-dimensional Reconstruction and Analysis of Structure Characteristics on Senile Plaques of Alzheimer’s Disease

Aβ-Aggregation-Generated Blue Autofluorescence Illuminates Senile Plaques as well as Complex Blood and Vascular Pathologies in Alzheimer's Disease

Aβ-Aggregation-Generated Blue Autofluorescence Illuminates Senile Plaques As Well As Complex Blood and Vascular Pathologies in Alzheimer’s Disease

Amyloid-β Plaques Enhance Alzheimer's Brain Tau-Seeded Pathologies by Facilitating Neuritic Plaque Tau Aggregation

Pathological Axonal Enlargement in Connection with Amyloidosis, Lysosome Destabilization and Hemorrhage is a Major Defect in the Alzheimer’s Disease

Pathological axonal enlargement in connection with amyloidosis, lysosome destabilization and hemorrhage is a major defect in Alzheimer's disease

Endothelial leakiness elicited by amyloid protein aggregation

Beta-Secretase-1 Elevation In Transgenic Mouse Models Of Alzheimer'S Disease Is Associated With Synaptic/Axonal Pathology And Amyloidogenesis: Implications For Neuritic Plaque Development

Contribution of blood platelets to vascular pathology in Alzheimer's disease.

Intraneuronal Abeta42 accumulation in human brain.

Not all plaques are created equal: Uncovering a unique molecular signature in Alzheimer's disease

Chemical imaging signatures delineate heterogeneous amyloid plaque populations across the Alzheimers disease spectrum

Delineating amyloid peptide signatures among heterogenous plaque population in Alzheimer’s Disease

Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation

White Matter Injury, Cholesterol Dysmetabolism, and APP/Abeta Dysmetabolism Interact to Produce Alzheimer’s Disease (AD) Neuropathology: A Hypothesis and Review

Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model

White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer's disease (AD) neuropathology: A hypothesis and review

Β‐secretase‐1 Elevation in Transgenic Mouse Models of Alzheimer’s Disease is Associated with Synaptic/axonal Pathology and Amyloidogenesis: Implications for Neuritic Plaque Development